Ibrutinib Combined with Bendamustine and Rituximab (BR) in Previously Treated Chronic Lymphocytic Leukemia/small Lymphocytic Lymphoma (CLL/SLL): First Results from a Randomized, Double-Blind, Placebo-Controlled, Phase III Study.
Journal of clinical oncology（2015）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined